Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03420430
Title Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care
Recruitment Temporarily not available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Genelux Corporation
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.